Workflow
SINOCHEM INTERNATIONAL(600500)
icon
Search documents
中化国际(600500) - 中化国际关于2024年度利润分配预案的公告
2025-04-29 12:19
| 证券代码:600500 | 证券简称:中化国际 | | | 编号:2025-024 | | --- | --- | --- | --- | --- | | 债券代码:138949 | 债券简称:23 | 中化 | K1 | | | 债券代码:241598 | 债券简称:24 | 中化 | K1 | | 中化国际(控股)股份有限公司 关于2024年度利润分配预案的公告 经第十届董事会第三次会议及第十届监事会第三次会议审议通过,2024 年 度拟不进行利润分配,也不进行资本公积金转增股本。本次利润分配预案尚需提 交股东大会审议。 中化国际(控股)股份有限公司(以下简称"公司")2024年度拟不进行 利润分配,也不进行资本公积转增股本。 本次利润分配方案已经公司第十届董事会第三次会议及第十届监事会第 三次会议审议通过,尚需提交公司2024年年度股东大会审议。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 2025 年 4 月 28 日,中化国际(控股)股份有限公司(以下简称"公司") 第十届董事会第三次会 ...
中化国际(600500) - 中化国际关于注册并发行超短期融资券的公告
2025-04-29 12:18
| 证券代码:600500 | 证券简称:中化国际 | | | 编号:2025-027 | | --- | --- | --- | --- | --- | | 债券代码:138949 | 债券简称:23 | 中化 | K1 | | | 债券代码:241598 | 债券简称:24 | 中化 | K1 | | 中化国际(控股)股份有限公司 关于注册并发行超短期融资券的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 2025 年 4 月 28 日,中化国际(控股)股份有限公司(以下简称"中化国际" 或"公司")召开第十届董事会第三次会议,审议通过了《关于公司注册并发行 超短期融资券的议案》。为了拓宽融资渠道,有效降低融资成本,满足公司生产 经营的流动资金需求,公司拟向中国银行间市场交易商协会申请注册并在中国境 内发行本金总额不超过人民币 60 亿元(含)的超短期融资券,具体内容如下: 一、同意注册不超过人民币 60 亿元(含 60 亿元)超短期融资券 1、发行规模:本次债券票面金额为人民币 100 元。本次发行的超短期融 ...
中化国际(600500) - 2025 Q1 - 季度财报
2025-04-29 12:08
Financial Performance - The company's operating revenue for Q1 2025 was ¥10,802,565,900.58, a decrease of 7.01% compared to ¥11,616,731,782.74 in the same period last year[4] - The net profit attributable to shareholders was -¥396,244,947.94, compared to -¥285,805,682.91 in the previous year, indicating a significant increase in losses[4] - The basic and diluted earnings per share were both -¥0.11, a decrease of ¥0.03 per share compared to -¥0.08 in the previous year[6] - The weighted average return on equity decreased by 1.34 percentage points to -3.20% from -1.86% in the previous year[6] - Net profit for Q1 2025 was a loss of ¥435,069,323.56, compared to a loss of ¥290,972,023.07 in Q1 2024, representing a 49.5% increase in loss[22] - The company reported a total comprehensive loss of ¥414,166,704.06 in Q1 2025, compared to a loss of ¥342,334,496.15 in Q1 2024[23] Cash Flow - The net cash flow from operating activities increased by 52.90%, reaching ¥378,876,820.95, up from ¥247,790,965.20 in the same period last year[4] - In Q1 2025, the net cash flow from operating activities was approximately ¥378.88 million, an increase of 52.9% compared to ¥247.79 million in Q1 2024[25] - Total cash inflow from operating activities in Q1 2025 was ¥12.13 billion, a decrease of 2.55% from ¥12.45 billion in Q1 2024[25] - Cash outflow from operating activities totaled ¥11.75 billion in Q1 2025, down 3.68% from ¥12.20 billion in Q1 2024[25] - The net cash flow from investing activities was -¥672.62 million in Q1 2025, an improvement from -¥924.72 million in Q1 2024[25] - Cash inflow from financing activities in Q1 2025 was ¥7.23 billion, slightly up from ¥7.18 billion in Q1 2024[25] - The net cash flow from financing activities increased to ¥1.58 billion in Q1 2025, compared to ¥1.09 billion in Q1 2024, marking a growth of 44.6%[25] - The ending cash and cash equivalents balance for Q1 2025 was ¥4.30 billion, significantly higher than ¥2.06 billion in Q1 2024[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥53,150,824,898.90, an increase of 3.90% from ¥51,155,797,592.30 at the end of the previous year[6] - The company's total assets amounted to ¥53,150,824,898.90 in Q1 2025, an increase from ¥51,155,797,592.30 in Q1 2024[19] - The company's total liabilities increased to ¥35,276,675,094.38 in Q1 2025 from ¥32,868,156,362.36 in Q1 2024, marking an increase of 12.3%[19] - Shareholders' equity attributable to shareholders decreased by 2.99% to ¥12,206,429,956.92 from ¥12,583,209,953.94 at the end of the previous year[6] - The total equity attributable to shareholders decreased to ¥12,206,429,956.92 in Q1 2025 from ¥12,583,209,953.94 in Q1 2024, a decline of 3.0%[19] Operational Efficiency - The company faced a continued low price environment for chemical products, impacting profitability significantly[8] - The operating rate of the core PDH unit reached 100%, with significant reductions in energy consumption and costs achieved in Q1 2025[13] - The company reported a significant improvement in the operating rate of the carbon three industry chain, indicating a positive trend in production efficiency[13] - The company is actively managing operational risks and optimizing core production operations to enhance efficiency and reduce costs[12] Research and Development - Research and development expenses for Q1 2025 were ¥140,380,390.67, down 11.4% from ¥158,596,264.14 in Q1 2024[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 69,384[10]
中化国际(600500) - 2024 Q4 - 年度财报
2025-04-29 12:08
Financial Performance - In 2024, the company achieved operating revenue of CNY 52.925 billion, a decrease of CNY 1.347 billion year-on-year, with a net profit attributable to shareholders of CNY -2.837 billion, down CNY 0.989 billion year-on-year[5]. - The company reported a net profit of -2,836,615,735.83 CNY for the year 2024, with a parent company net profit of -1,995,882,880.45 CNY[66]. - The basic earnings per share for 2024 was -¥0.79, down from -¥0.52 in 2023, reflecting a decline in profitability[85]. - The total assets at the end of 2024 were approximately ¥51.16 billion, a decrease of 5.12% from ¥53.92 billion at the end of 2023[84]. - The weighted average return on net assets was -20.18% for 2024, a decrease of 8.99 percentage points from -11.19% in 2023[85]. - The net cash flow from operating activities was approximately ¥1.16 billion, a decrease of 31.79% compared to ¥1.70 billion in the previous year[84]. - The company plans to not distribute profits for the year 2024 due to reported losses and negative retained earnings[66]. - The company reported a total revenue of 1,048.89 million CNY for the reporting period, with a net profit of 442.29 million CNY[166]. Market and Product Development - The company focused on core business areas, increasing R&D investment to CNY 0.776 billion, with new product sales revenue reaching CNY 9.703 billion[6]. - Key product sales showed growth, with anti-aging agent sales up 6.26%, bisphenol A sales up 32.40%, epoxy resin sales up 23.49%, and nylon 66 sales up 70.99% year-on-year[7]. - The company aims to strengthen its position in the chemical new materials sector, focusing on innovation and addressing key technological bottlenecks[22]. - The company achieved a 24% year-on-year increase in product sales in the basic raw materials and intermediates segment, with revenue reaching CNY 766,167.55 million, a 20.27% increase year-on-year[28]. - The high-performance materials segment generated revenue of CNY 927,611.13 million, reflecting a 9.56% year-on-year growth despite a decline in chemical new material prices[35]. - The company is actively promoting the construction of a 1,500 tons/year LCNT product and a customized R&D platform to accelerate industrial transformation in the pharmaceutical sector[48]. - The company is exploring potential mergers and acquisitions to enhance its market position[76]. Operational Efficiency and Capacity - The production capacity utilization rate for major facilities improved, with the output of the carbon three industry chain products reaching 1.84 million tons, an increase of 89% year-on-year[8]. - The company holds the leading position in the domestic market for epoxy chloropropane with a production capacity of 25,000 tons/year, supported by advanced technology and stable production[26]. - The company’s nylon 66 project has a production capacity of 40,000 tons/year, with plans for expansion to enhance market influence and profitability[32]. - The company’s epoxy resin production capacity is expected to exceed 340,000 tons/year by the end of 2024, driven by increasing domestic demand in electronics and wind power sectors[36]. - The company has established a fully integrated industrial chain for epoxy resin, enhancing its competitive advantage through self-supplied raw materials[31]. - The company reported a production capacity utilization rate of 103.83% for caustic soda, 104.69% for aniline, and 106.50% for chlorobenzene, indicating strong operational efficiency[131]. Challenges and Industry Trends - The average price of international crude oil fluctuated between USD 70-90 per barrel, contributing to ongoing cost pressures in the chemical industry[19]. - The domestic chemical industry continues to face challenges with low product prices and high raw material costs, impacting overall profitability[19]. - The domestic production capacity of Nylon 66 has rapidly expanded, resulting in a downward trend in overall industry prices, enhancing competitiveness in emerging applications like new energy vehicles[38]. - The ABS market is projected to see increased supply due to new capacity releases, but significant growth in downstream demand is lacking, leading to a relaxed supply-demand relationship[37]. - The company is focusing on green and clean processes in response to industry trends, with a commitment to eliminating outdated production methods by 2025[29]. Research and Development - The company has made significant progress in R&D, with breakthroughs in high-performance engineering plastics and water-based epoxy flooring coatings, achieving small batch trial production[60]. - The number of R&D personnel is 702, accounting for 7.33% of the total workforce[111]. - Total R&D investment amounted to ¥775,989,669.53, representing 1.47% of operating revenue[110]. - The proportion of capitalized R&D expenses is 21.16% of total R&D investment[110]. - The company is actively engaged in research and development to improve production processes and develop new chemical materials[125]. Financial Management and Strategy - The company expanded its bank credit scale to 91.4 billion CNY by the end of 2024, with a comprehensive financing cost of 2.8%[61]. - The company successfully issued 60 billion CNY in short-term financing bonds at an average interest rate of 1.88%[61]. - The company is exploring potential acquisitions to enhance its market position, with a budget of $200 million allocated for this purpose[168]. - The company plans to prioritize external medium to long-term financing to supplement capital and funds, while conducting monthly and quarterly cash flow analyses[156]. - The company has implemented a procurement strategy to mitigate risks associated with raw material price fluctuations[136]. Governance and Compliance - The board of directors consists of 7 members, including 3 independent directors, ensuring a majority in key committees for oversight[160]. - The supervisory board has 3 members, diligently reviewing financial reports and overseeing major investment decisions[161]. - The company maintains transparency in information disclosure, adhering to legal requirements and enhancing the quality of disclosures[162]. - There were no significant accounting errors or omissions during the reporting period, further improving disclosure quality[162]. - The company has implemented measures to prevent insider trading and ensure fair information disclosure practices[162]. Employee and Talent Management - The company achieved a 2% increase in the proportion of high-skilled talents, reaching 27%[56]. - The company is focusing on talent development, adding 3 national-level high-level talents and 6 provincial-level talents during the year[55]. - The company has established a market-oriented compensation system, ensuring employee salaries are competitive and aligned with company performance[192]. - The company plans to implement a leadership training program aimed at enhancing political literacy and management capabilities among its managers and high-potential talents[193].
中化国际(600500) - 中化国际2024年内部控制审计报告
2025-04-29 12:07
内部控制审计报告 KPMG Huazhen LLP 8th Floor, KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax kpmg.com/cn Internet 毕马威华振审字第 2515535 号 中化国际(控股)股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我们审 计了中化国际(控股)股份有限公司(以下简称 "中化国际")2024 年 12 月 31 日的 财务报告内部控制的有效性。 一、企业对内部控制的责任 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86(10) 8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 内部控制审计报告 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审计 意见,并对注意到的非财务 ...
中化国际(600500) - 会计师事务所关于中化国际(控股)股份有限公司2024年度营业收入扣除情况的专项说明
2025-04-29 12:07
关于中化国际(控股)股份有限公司 2024 年度营业收入扣除情况的专项说明 KPMG Huazhen LLP 8th Floor, KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86 (10) 8508 5000 传真 +86(10)8518 5111 网址 kpmg.com/cn 关于中化国际(控股) 股份有限公司 2024 年度营业收入扣除情况的专项说明 毕马威华振专字第 2503248 号 中化国际(控股)股份有限公司董事会: 我们接受委托,按照中国注册会计师审计准则审计了中化国际(控股)股份有限公司(以 下简称"中化国际")2024 年度的财务报表,包括 2024 年 12 月 31 日的合并及母公司资产 负债表,2024 年度的合并及母公司利润 ...
中化国际(600500) - 会计师事务所关于中化国际(控股)股份有限公司2024年度涉及财务公司关联交易的存款、贷款等金融业务汇总表的专项说明
2025-04-29 12:07
KPMG Huazhen LLP 8th Floor. KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码:100738 电话 +86(10)8508 5000 传真 +86(10)8518 5111 网址 kpmg.com/cn 关于中化国际 (控股) 股份有限公司 关于中化国际 (控股) 股份有限公司 2024 年度涉及财务公司关联交易的存款、贷款等金融业务汇总表的专项说明 2024 年度涉及财务公司关联交易的存款、贷款等金融业务汇总表的专项说明 毕马威华振专字第 2503238 号 中化国际 (控股) 股份有限公司董事会: 我们接受委托,按照中国注册会计师审计准则审计了中化国际(控股)股份有限公司 (以下 简称"中化国际")2024年度的财务报表,包括 2024 年 12 月 ...
中化国际(600500) - 会计师事务所关于中化国际2024年度非经营性资金占用及其他关联资金往来情况专项说明
2025-04-29 12:07
关于中化国际(控股)股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审计报告 目 录 1、 专项审计报告 2、 附表 委托单位:中化国际(控股)股份有限公司 审计单位:毕马威华振会计师事务所(特殊普通合伙) 联系电话:021-68370360 关于中化国际(控股)股份有限公司 2024 年度非经营性资金占用及其他关联资金往来情况表 非经营性资金 占用 资金占用方 名称 占用方与上 市公司的关 联关系 上市公 司核算 的会计 科目 2024 年期 初占用资 金余额 2024 年度占 用累计发生 金额(不含利 息) 2024 年度 占用资金 的利息 (如有) 2024 年度偿 还累计发生 金额 2024 年期 末占用资 金余额 占用形成 原因 占用性 质 现控股股东、 实际控制人及 其附属企业 非经营 性占用 非经营 性占用 小计 / / / / / 前控股股东、 实际控制人及 其附属企业 非经营 性占用 非经营 性占用 小计 / / / / / 其他关联方及 其附属企业 非经营 性占用 非经营 性占用 小计 / / / / / 总计 / / / / / 其他关联资金 往来 资金往来方 名称 往 ...
中化国际(600500) - 中化国际2024年财务审计报告
2025-04-29 12:05
自 2024 年 1 月 1 日 至 2024 年 12 月 31 日止年度财务报表 中化国际 (控股) 股份有限公司 KPMG Huazhen LLP 8th Floor. KPMG Tower Oriental Plaza 1 East Chang An Avenue Beijing 100738 China Telephone +86 (10) 8508 5000 +86 (10) 8518 5111 Fax Internet kpmg.com/cn 毕马威华振会计师事务所 (特殊普通合伙) 中国北京 东长安街1号 东方广场毕马威大楼8层 邮政编码 : 100738 电话 +86 (10) 8508 5000 传真 +86 (10) 8518 5111 网址 kpmg.com/cn 审计报告 毕马威华振审字第 2515894 号 中化国际(控股) 股份有限公司全体股东: 一、审计意见 我们审计了后附的中化国际(控股)股份有限公司(以下简称"中化国际")财务报表,包 括 2024 年 12 月 31 日的合并及母公司资产负债表,2024 年度的合并及母公司利润表、合并及 母公司现金流量表、合并及母公司股东 ...
中化国际:2025年第一季度净亏损3.96亿元
news flash· 2025-04-29 10:31
中化国际(600500)公告,2025年第一季度营业收入108.03亿元,同比下降7.01%。净亏损3.96亿元, 去年同期净亏损2.86亿元。 ...